Post hoc analysis of patient responses by T315I mutation status from the 3-year update of the optic trial: A dose-optimization study of 3 starting doses of ponatinib Meeting Abstract
| Authors: | Cortes, J.; Deininger, M.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; McCloskey, J.; Rousselot, P.; Rosti, G.; de Lavallade, H.; Rojas, C.; Turkina, A.; Talpaz, M.; Mauro, M.; Lu, V.; Vorog, A.; Apperley, J. |
| Abstract Title: | Post hoc analysis of patient responses by T315I mutation status from the 3-year update of the optic trial: A dose-optimization study of 3 starting doses of ponatinib |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | tki; ponatinib; optic; t315i; cpcml |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S338 |
| Language: | English |
| ACCESSION: | WOS:001062479600267 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01134-5 |
| Notes: | Meeting Abstract: CML-313 -- Source: Wos |
